Apollo, GlaxoSmithKline shares surge on MSCI inclusion

JM Financial, GlaxoSmithkline Consumer Healthcare, ABB and Oracle Financial Services are among the other stocks to see a surge in volumes on BSE today, 17 May 2013. Supreme Industries clocked volume of 2.51 lakh shares by 13:38 IST on BSE, a ...

GlaxoSmithkline Consumer Healthcare fell 4.86% to Rs 4,846.50 at 10:43 IST on BSE on profit booking after the stock jumped 30.60% in the preceding seven trading sessions to Rs 5093.95 on 17 May 2013 from a recent low of Rs 3900.30 on 9 May 2013.

Key benchmark indices were range bound in early afternoon trade.

Drug-maker GlaxoSmithKline Pharmaceuticals said that its growth of the core pharmaceuticals business suffered on account of supply chain constraints in parts of its Nashik facility as well as some...

Shares of GlaxoSmithKline (NYSE:GSK) traded today at $52.65, breaking its 52-week high. So far today approximately 2 million shares have been exchanged, as compared to an average 30-day volume of 3.2 million shares. Over the past year, ...

GlaxoSmithKline Pharmaceuticals' first quarter (January-March) net profit rose by 37.4 percent year-on-year to Rs 169 crore, sending its shares 6 percent higher.

The revenues for the quarter are seen at Rs 702 crore, up 11 per cent, as against Rs 630 crore in the same period a year ago.

GlaxoSmithkline Consumer Healthcare at its meeting held on May 01, 2013, has noted the withdrawal of nomination by Horlicks Limited of Mr. Simon Scarff as the Director of the Company and as the Chairman of the Board w.e.f. close of business hours as on April ...

GlaxoSmithkline (GSK) Consumer Healthcare is trading lower by 3.5% to Rs 3,935 extending its previous day’s 3% fall after the packaging foods maker said its chairman, Simon Scarff, has expressed his wish to step down from April 30, 2013.